AMBSAmarantus BioScience Holdings, Inc.
Nov 12, 2026 — Q3 2026 Earnings Report & Solvency Update
Chart by TradingViewThe schedule
- Thu12Nov
AMBS is expected to file its next quarterly financial results. Given the $36.8K market capitalization and $0 cash balance, the focus will be entirely on basic solvency metrics and any disclosures regarding shell status or operations suspension.
- Wed20Jan
Due to massive operational leverage and a -4.2x EV/EBITDA ratio with unserviceable debt, creditor intervention, toxic financing, or formal liquidation proceedings are heavily anticipated events in the first quarter of the year.
- Tue30Mar
Filing of the annual 10-K report. The market will look for the auditor's going-concern opinion and any last-resort capital raise efforts resulting in catastrophic share dilution.